UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis

PLoS medicine, 2015-02, Vol.12 (2), p.e1001789-e1001789

2015

Link zum Volltext

Verfügbarkeit prüfen

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

The Journal of pathology, 2020-03, Vol.250 (3), p.336-345

2020

Link zum Volltext

Verfügbarkeit prüfen

Evolution of platinum resistance in high-grade serous ovarian cancer

The lancet oncology, 2011-11, Vol.12 (12), p.1169-1174

2011

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Nature (London), 2013-05, Vol.497 (7447), p.108-112

2013

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA

Science translational medicine, 2012-05, Vol.4 (136), p.136ra68

2012

Link zum Volltext

Verfügbarkeit prüfen

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

PLoS medicine, 2016-12, Vol.13 (12), p.e1002198-e1002198

2016

Link zum Volltext

Verfügbarkeit prüfen

scAbsolute: measuring single-cell ploidy and replication status

Genome Biology, 2024-03, Vol.25 (1), p.62-62

2024

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes

PloS one, 2014-09, Vol.9 (9), p.e103988-e103988

2014

Link zum Volltext

Verfügbarkeit prüfen

Phylogenetic quantification of intra-tumour heterogeneity

PLoS computational biology, 2014-04, Vol.10 (4), p.e1003535-e1003535

2014

Link zum Volltext

Verfügbarkeit prüfen

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

The Journal of pathology, 2010-05, Vol.221 (1), p.49-56

2010

Link zum Volltext

Verfügbarkeit prüfen

Refined characterization of circulating tumor DNA through biological feature integration

Scientific reports, 2022-02, Vol.12 (1), p.1928-1928, Article 1928

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

The journal of pathology. Clinical research, 2016-10, Vol.2 (4), p.247-258

2016

Link zum Volltext

Verfügbarkeit prüfen

Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer

BMC cancer, 2017-09, Vol.17 (1), p.657-657, Article 657

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?

Journal of clinical oncology, 2005-10, Vol.23 (29), p.7350-7360

2005

Link zum Volltext

Verfügbarkeit prüfen

SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells

PloS one, 2016-09, Vol.11 (9), p.e0162698-e0162698

2016

Link zum Volltext

Verfügbarkeit prüfen

Genomic landscape of platinum resistant and sensitive testicular cancers

Nature communications, 2020-05, Vol.11 (1), p.2189-2189, Article 2189

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular landscape and functional characterization of centrosome amplification in ovarian cancer

Nature communications, 2023-10, Vol.14 (1), p.6505-6505, Article 6505

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier

Genome biology, 2014-12, Vol.15 (12), p.526-526, Article 526

2014

Link zum Volltext

Verfügbarkeit prüfen

Semiquantitative and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging Measurements Predict Radiation Response in Cervix Cancer

International journal of radiation oncology, biology, physics, 2009-07, Vol.74 (3), p.766-773

2009

Link zum Volltext

Verfügbarkeit prüfen

Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer

Nature communications, 2023-10, Vol.14 (1), p.6756-6756, Article 6756

2023

Link zum Volltext

Verfügbarkeit prüfen

Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs

Cancer cell, 2007-06, Vol.11 (6), p.498-512

2007

Link zum Volltext

Verfügbarkeit prüfen

Development of Cell‐Permeable, Non‐Helical Constrained Peptides to Target a Key Protein–Protein Interaction in Ovarian Cancer

Angewandte Chemie (International ed.), 2017-01, Vol.56 (2), p.524-529

International ed. in English, 2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathogenesis of ovarian clear cell carcinoma

Future oncology (London, England), 2015-05, Vol.11 (9), p.1389

2015

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models

EMBO molecular medicine, 2022-08, Vol.14 (8), p.e15729-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells

Molecular cancer, 2012-05, Vol.11 (1), p.36-36

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 314

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Englisch
(312)
Japanisch
(58)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

Evolution of platinum resistance in high-grade serous ovarian cancer

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

scAbsolute: measuring single-cell ploidy and replication status

Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes

Phylogenetic quantification of intra-tumour heterogeneity

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

Refined characterization of circulating tumor DNA through biological feature integration

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer

Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?

SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells

Genomic landscape of platinum resistant and sensitive testicular cancers

Molecular landscape and functional characterization of centrosome amplification in ovarian cancer

Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier

Semiquantitative and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging Measurements Predict Radiation Response in Cervix Cancer

Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer

Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs

Development of Cell‐Permeable, Non‐Helical Constrained Peptides to Target a Key Protein–Protein Interaction in Ovarian Cancer

Molecular pathogenesis of ovarian clear cell carcinoma

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models

ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells

Suchergebnisse filtern